ArticleScientific reports2025
Development and theoretical investigation of antimony-based halide perovskite solar cell using kesterite as hole transport material.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cesium antimony iodide (Cs₃Sb₂I₉) is a lead-free halide perovskite attracting significant attention due to its tunable bandgap, unique optoelectronic properties, and potential as a light-absorbing material in perovskite solar cells (PSCs). Kesterite CZTSe, a stable, non-toxic, and cost-effective material that facilitates efficient hole extraction, reduces recombination, and is compatible with lead-free perovskites, is employed in this study as a novel hole transport layer (HTL) for high-performance, sustainable solar cells. The influence of various parameters on the device's performance with the general architecture of FTO/WS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.